Vigroz MV 1mg/500mg/0.2mg Tablet
Manufacturer
Zylig Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Key Information
Short Description
Vigroz MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Vigroz MV 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. It is a category of medicines known as anti-diabetic drugs.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vigroz MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
How it works
Vigroz MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Ozomet VG 1mg/500mg/0.2mg Tablet
StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.2mg Tablet
Practomet VG 1mg/500mg/0.2mg Tablet
Voglisure-GM 1 Tablet
Glimizest MV 1mg/500mg/0.2mg Tablet
Glimibrit MV 1mg/500mg/0.2mg Tablet
Glimijen VM 1mg/500mg/0.2mg Tablet
Vokem GM 1mg/500mg/0.2mg Tablet
Vopride MG 1mg/500mg/0.2mg Tablet
Vogmax GM 1mg/500mg/0.2mg Tablet
Frequently asked questions
What is Vigroz MV 1mg/500mg/0.2mg Tablet?
Vigroz MV 1mg/500mg/0.2mg Tablet contains Glimepiride, Metformin and Voglibose – a combination used to treat type 2 diabetes mellitus (DM). It helps control blood sugar levels when taken with dietary changes and regular exercise. Glimepiride increases insulin release from the pancreas, metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose inhibits alpha-glucosidase activity to lower postprandial glucose levels. This combination is not for Type 1 DM treatment.
What are the possible side effects of Vigroz MV 1mg/500mg/0.2mg Tablet?
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infections.
Are there any specific conditions in which Vigroz MV 1mg/500mg/0.2mg Tablet should not be taken?
Vigroz MV 1mg/500mg/0.2mg Tablet should not be taken by individuals with known allergies to its components or excipients. It is also contraindicated in patients with moderate to severe kidney disease and inflammatory bowel disease, colonic ulceration, or underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Vigroz MV 1mg/500mg/0.2mg Tablet?
No, combining Vigroz MV 1mg/500mg/0.2mg Tablet with alcohol may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Vigroz MV 1mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, using Vigroz MV 1mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications together.
What are the instructions for storage and disposal of Vigroz MV 1mg/500mg/0.2mg Tablet?
Store this medicine in its original packaging, tightly closed, according to the instructions provided on the label or package insert. Do not discard the unused medicine. Ensure it is unavailable to pets, children and other individuals.
